In total, studies of hepatocyte-specific PLIN2 deficiency suggest that hepatic PLIN2 does not affect the onset or severity of common metabolic complications associated with NAFLD at any stage of the disease progression. The gene discussed is PLIN2; the disease is metabolic dysfunction-associated steatotic liver disease.